0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home
Back Home

Kevin Marsh


425 results

Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.Bejon P, Mwangi T, Lowe B, Peshu N, Hill AV, Marsh K
Vaccine, (2007). 25:8198-202

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, Osier FH, Bancone G, Avellino P, Blot I, Fegan G, Bull PC, Williams TN, Conway DJ, Marsh K, Modiano D
PLoS One, (2007). 2:e978

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B, Lang T, Mwangi TW, Gilbert SC, Peshu N, Marsh K, Hill AV
J Immunol, (2007). 179:4193-201

Defining childhood severe falciparum malaria for intervention studies.Bejon P, Berkley JA, Mwangi T, Ogada E, Mwangi I, Maitland K, Williams T, Scott JA, English M, Lowe BS, Peshu N, Newton CR, Marsh K
PLoS Med, (2007). 4:e251

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Ogada E, Mwangi T, Milligan P, Lang T, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS One, (2007). 2:e707

Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.Khor CC, Vannberg FO, Chapman SJ, Walley A, Aucan C, Loke H, White NJ, Peto T, Khor LK, Kwiatkowski D, Day N, Scott A, Berkley JA, Marsh K, Peshu N, Maitland K, Williams TN, Hill AV
Genes Immun, (2007). 8:570-6

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K
Parasite Immunol, (2007). 29:387-94

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, Marsh K, Cutts FT
J Infect Dis, (2007). 196:550-7

Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa.Beeson JG, Ndungu F, Persson KE, Chesson JM, Kelly GL, Uyoga S, Hallamore SL, Williams TN, Reeder JC, Brown GV, Marsh K
Am J Trop Med Hyg, (2007). 77:22-8

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.Kinyanjui SM, Conway DJ, Lanar DE, Marsh K
Malar J, (2007). 6:82

Plasmodium falciparum intercellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells.Jenkins N, Wu Y, Chakravorty S, Kai O, Marsh K, Craig A
J Infect Dis, (2007). 196:321-7

Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children.Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J, Crawley J, Fegan G, Bauni E, Peshu N, Marsh K, Neville B, Newton C
JAMA, (2007). 297:2232-40

An approach to classifying sequence tags sampled from Plasmodium falciparum var genes.Bull PC, Kyes S, Buckee CO, Montgomery J, Kortok MM, Newbold CI, Marsh K
Mol Biochem Parasitol, (2007). 154:98-102

Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates.Deans AM, Nery S, Conway DJ, Kai O, Marsh K, Rowe JA
Infect Immun, (2007). 75:3014-20

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV
Nat Genet, (2007). 39:523-8

The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya.Atkinson SH, Mwangi TW, Uyoga SM, Ogada E, Macharia AW, Marsh K, Prentice AM, Williams TN
Clin Infect Dis, (2007). 44:802-9

Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue.Cordery DV, Kishore U, Kyes S, Shafi MJ, Watkins KR, Williams TN, Marsh K, Urban BC
J Infect Dis, (2007). 195:905-12

Sickle cell disease in Africa: burden and research priorities.Makani J, Williams TN, Marsh K
Ann Trop Med Parasitol, (2007). 101:3-14

Elevated plasma urokinase receptor predicts low birth weight in maternal malaria.Ostrowski SR, Shulman CE, Peshu N, Staalsoe T, Hoyer-Hansen G, Pedersen BK, Marsh K, Ullum H
Parasite Immunol, (2007). 29:37-46

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS Clin Trials, (2006). 1:e29